Cosmetics News In Brief: ECHA Makes Non-Confidential REACH Data More Accessible

Stakeholders can now download a database of key study results for nearly 15,000 chemicals registered under the EU’s REACH regulation, benefiting from streamlined access to information that previously was more of a chore to compile, the European Chemicals Agency says. More news in brief.

Researchers, regulators, companies and other stakeholders stand to benefit from a newly launched IUCLID portal that facilitates access to key study data submitted under the EU’s REACH regulation. According to a March 23 announcement from the European Chemicals Agency, the information represents a subset of non-confidential data on roughly 15,000 chemicals that is already published on the agency’s website. But whereas users of that gateway must search for one chemical at a time, the new platform gives registered users the ability to download free-of-charge a database of study results for all chemicals, in reduced form, relating to physical-chemical properties, toxicology profiles, and environmental fates and hazards. “ECHA believes that making this data downloadable will be yet another step forward towards the goals of REACH – both in terms of improving the safe use of chemicals, for example through improved safety data sheets, and the development and use of alternative methods,” minimizing the need for animal testing, the agency says. The European chemical industry association Cefic welcomes the development, calling it a “win-win for all stakeholders.”

Following President Donald Trump’s proposed 31% cut to Environmental Protection Agency funding, cosmetics industry stakeholders are petitioning Administrator Scott Pruitt...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Regulation

UK Org ‘Snapshot’ Sampling: Most Third-Party Beauty On Four Ecommerce Sites ‘Likely’ Counterfeit

 

UK consumer advocacy organization finds more than two-thirds of 34 skin care and makeup products it purchased from third party sellers on major ecommerce sites are likely fake.

EU Green Claims Directive: Commission Says It ‘Has Not Withdrawn’ From Negotiations

 
• By 

What's going on with the EU Green Claims Directive? HBW Insight speaks to the European Commission, Parliament and Council to find out why trilogue negotiations seem to have stalled.

US FDA: No Replacement Yet For Animal Methods In Testing Systemic Effects Of Sunscreens

 
• By 

While FDA fully supports the recent roadmap to reduce and eliminate animal testing, animal tests are still necessary for assessing systemic effects, says Jacqueline Corrigan-Curay, acting director for CDER, during a House Energy and Commerce Health Subcommittee hearing.

EU Proposal To Simplify Hazardous Chemical Rules For Cosmetics ‘Step In Right Direction’ - Industry

 

The European Commission’s Simplification Omnibus published July 8 is ‘step in right direction’ for streamlining processes and providing more legal certainty and predictability for regulations addressing cosmetics, says Cosmetics Europe.

More from Policy & Regulation

Producers Sue Oregon Over ‘Crushing’ EPR Recycling Law, Call It Unconstitutional

 

A national wholesalers’ trade group is suing Oregon, claiming its EPR law, which requires producers to register, report packaging data and pay fees, is unconstitutional and overly burdensome.

Senate HELP Committee Adds Sunscreen Regulation Overhaul To OMUFA Reauthorization

 
• By 

OMUFA reauthorization bill including amendment with sunscreen regulation provisions passed by Senate committee, which also approved other provisions not included in House OMUFA bill.

Sunscreen Regulation Reforms Still Could Hitch Ride On Senate OMUFA Reauthorization Bill

As stakeholders and lawmakers pin their hopes on OMUFA reauthorization as a vehicle for enacting sunscreen regulatory changes, Senate version of the bill could be the ticket after a sunscreen-specific amendment withdrawn in the House.